Stephen L. Lowe

4.2k citations

77 papers · 2.8k indexed · 1 hit paper · h-index 23

Impact in

Biological Psychiatry top 1%
- Tryptophan and brain disorders
Cellular and Molecular Neuroscience top 1%
- Neuroscience and Neuropharmacology Research
- Neurotransmitter Receptor Influence on Behavior

Papers in

Cellular and Molecular Neuroscience 20
- Neuroscience and Neuropharmacology Research 14
Behavioral Neuroscience 3

Co-authors: D. M. Bowen Paul T. Francis Andrew Procter Alan M. Palmer Siew Heng Wong David Neary Ferenc Martényi Kimberley Jackson
Journals: Alzheimer s & Dementia (10 papers)British Journal of Clinical Pharmacology (3 papers)Journal of Neurochemistry (3 papers)Biochemical Society Transactions (3 papers)The Journal of Clinical Pharmacology (3 papers)
Partner nations: United States Singapore United Kingdom

In The Last Decade

Stephen L. Lowe

74 papers receiving 2.7k citations

Hit Papers

align trajectories log scale

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial 2007 · 790 citations

Peers

Countries citing papers authored by Stephen L. Lowe

Since Specialization

Citations

This map shows the geographic impact of Stephen L. Lowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen L. Lowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen L. Lowe more than expected).

Fields of papers citing papers by Stephen L. Lowe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen L. Lowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen L. Lowe. The network helps show where Stephen L. Lowe may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Stephen L. Lowe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stephen L. Lowe Line = papers co-authored together Stephen L. Lowe links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Reliability of dynamic causal modelling of resting‐state magnetoencephalography Human Brain Mapping ·Amirhossein Jafarian, Mouren Wuarlela, Ece Kocagöncü, Sung Jae Shin, Taı̈ssia Lelekov-Boissard, T Hlasek, Andrew J. Quinn, A M Halleaux, Vanessa Raymont, Stephen L. Lowe, Krish D. Singh, Mark W. Woolrich, Anna C. Nobre, Richard N. Henson, Karl Friston, James B. Rowe	2024	3
2	Safety, Tolerability, and Pharmacokinetics of Zagotenemab in Participants with Symptomatic Alzheimer’s Disease: A Phase I Clinical Trial Journal of Alzheimer s Disease Reports ·Brian A. Willis, Albert Lo, Jeffrey L. Dage, Sergey Shcherbinin, Rogelio Sanchez-Verin-Lucio, Scott W. Andersen, Elizabeth LaBell, David Pérahia, Paula M. Hauck, Stephen L. Lowe	2023	8
3	Safety, tolerability, and pharmacokinetic evaluation of single‐ and multiple‐ascending doses of a novel kappa opioid receptor antagonist LY2456302 and drug interaction with ethanol in healthy subjects The Journal of Clinical Pharmacology ·Stephen L. Lowe, Conrad J. Wong, Jennifer Witcher, Celedon Gonzales, Gemma L. Dickinson, Robert L. Bell, Linda Rorick‐Kehn, Mohammad Alrawi, R Stoltz, Jane Royalty, Sitra Tauscher‐Wisniewski	2014	81
4	The Effects on Metabolic Clearance when Administering a Potent CYP3A Autoinducer with the Prototypic CYP3A Inhibitor, Ketoconazole Drug Metabolism and Disposition ·Gözdem Dittel, Brian A. Willis, Francisco Bruno Forte Rocha, Stephen L. Lowe, Stuart Friedrich, Amparo de la Peña, Wei Zhang, Thomas J. Brown, Stephen D. Wise, Stephen D. Hall	2012	1
5	Adverse Events in Healthy Subjects Exposed to Single and Multiple Doses of LY2140023 Monohydrate Journal of Clinical Psychopharmacology ·Gözdem Dittel, Eratóstenes Edson Ramalho de Araújo, Stephen L. Lowe, Ludmila Kryzhanovskaya, Daniel Walker, Bruce J. Kinon	2012	3
6	Semagacestat Pharmacokinetics Are Not Significantly Affected by Formulation, Food, or Time of Dosing in Healthy Participants The Journal of Clinical Pharmacology ·Brian A. Willis, Wei Zhang, Gözdem Dittel, Stephen L. Lowe, Francisco Bruno Forte Rocha, Troy Rolison, Stuart Friedrich, Amparo de la Peña	2011	9
7	Identification of specific calcitonin-like receptor residues important for calcitonin gene-related peptide high affinity binding BMC Pharmacology ·Sugato Banerjee, L Török, Erik Harris, Stephen L. Lowe, Kathryn A. Thomasson, James E. Porter	2006	19
8	l-5-Hydroxytryptophan augments the neuroendocrine response to a SSRI Psychoneuroendocrinology ·Stephen L. Lowe, Kwee Poo Yeo, Ariane Vieira, Danny Soon, Alan X. Pan, Stephen D. Wise, Richard Peck	2005	14
9	Brownian dynamics simulations of glycolytic enzyme subsets with F‐actin Biopolymers ·Stephen L. Lowe, Charlotte L. Adrian, I. V. Uporov, Fara Devi Indah Permatasari, Kathryn A. Thomasson	2003	16
10	GS32, a Novel Golgi SNARE of 32 kDa, Interacts Preferentially with Syntaxin 6 Molecular Biology of the Cell ·Siew Heng Wong, Yue Xu, Tao Zhang, Gareth Griffiths, Stephen L. Lowe, V. Nathan Subramaniam, Kah Tong Seow, Wanjin Hong	1999	64
11	A SNARE involved in protein transport through the Golgi apparatus Nature ·Stephen L. Lowe, Frank Peter, V. Nathan Subramaniam, Siew Heng Wong, C. Chen	1997	76
12	Analgesia after inguinal herniorrhaphy with laparoscopic inspection of the peritoneum in children. Caudal block versus ilioinguinal/iliohypogastric block. PubMed ·Joseph D. Tobias, George Holcomb, John W. Brock, Walter M. Morgan, Carlos Panfilo Bustincio Teves, Stephen L. Lowe, Gail E. Rasmussen	1995	8
13	Characterisation of the Glycine Modulatory Site of the N‐Methyl‐d‐Aspartate Receptor‐Ionophore Complex in Human Brain Journal of Neurochemistry ·Andrew Procter, Gary C. Stratmann, Paul T. Francis, Stephen L. Lowe, Paulo Henrique Ferreira Bertolucci, D. M. Bowen	1991	28
14	The influence of tetrahydro 9 aminoacridine on excitatory amino acid neurotransmission in vivo and in vitro British Journal of Pharmacology ·Janet Steele, Alan M. Palmer, Stephen L. Lowe, D. M. Bowen	1989	2
15	Reduced Glycine Stimulation of [³H]MK‐801 Binding in Alzheimer's Disease Journal of Neurochemistry ·Andrew Procter, Alan Fernando Bangun, Gary C. Stratmann, Stephen L. Lowe, D. M. Bowen	1989	97
16	Brain amino acid concentrations and Ca2+-dependent release in intractable depression assessed antemortem Brain Research ·Paul T. Francis, Amanda Poynton, Stephen L. Lowe, A. Najlerahim, P. K. Bridges, John R. Bartlett, Andrew Procter, C. J. Bruton, D. M. Bowen	1989	67
17	Extracellular concentrations of aspartate and glutamate in rat neostriatum following chemical stimulation of frontal cortex Experimental Brain Research ·Alan M. Palmer, P.H. Hutson, Stephen L. Lowe, D. M. Bowen	1989	56
18	Topographical distribution of neurochemical changes in Alzheimer's disease Journal of the Neurological Sciences ·Andrew Procter, Stephen L. Lowe, Alan M. Palmer, Paul T. Francis, Margaret M. Esiri, Gary C. Stratmann, A. Najlerahim, Ambrish J. Patel, C. Anthony Hunt, David M. Bowen	1988	113
19	Evidence of Glutamatergic Denervation and Possible Abnormal Metabolism in Alzheimer's Disease Journal of Neurochemistry ·Andrew Procter, Alan M. Palmer, Paul T. Francis, Stephen L. Lowe, David Neary, Elaine Murphy, Yufei ZHANG, D. M. Bowen	1988	152
20	Clinical Evaluation of a Combination of Droperidol and Fentanyl as an Anesthetic for the Rat and Hamster Journal of the American Veterinary Medical Association ·Oscar Fabián Nieto Castillo, Stephen L. Lowe, Kornelija Jankauskaitė	1972	5

About Stephen L. Lowe

Stephen L. Lowe is a scholar working on Cellular and Molecular Neuroscience, Behavioral Neuroscience, Physiology, Pharmacology and Biochemistry, having authored 77 papers that have together received 2.8k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (14 papers), Alzheimer's disease research and treatments (11 papers), Receptor Mechanisms and Signaling (8 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (6 papers), Cholinesterase and Neurodegenerative Diseases (6 papers), Protein Structure and Dynamics (5 papers), Memory and Neural Mechanisms (5 papers) and Pharmacogenetics and Drug Metabolism (4 papers). The work is most often cited by research in Biological Psychiatry (268 citations), Cellular and Molecular Neuroscience (1.3k citations), Physiology (737 citations), Psychiatry and Mental health (405 citations) and Pharmacology (437 citations). Stephen L. Lowe has collaborated with scholars based in United States, Singapore and United Kingdom. Frequent co-authors include D. M. Bowen, Paul T. Francis, Andrew Procter, Alan M. Palmer, Siew Heng Wong, David Neary, Ferenc Martényi, Kimberley Jackson, Bryan G. Johnson and Andreev Bv. Their work appears in journals such as Alzheimer s & Dementia, British Journal of Clinical Pharmacology, Journal of Neurochemistry, Biochemical Society Transactions and The Journal of Clinical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact